Together, this evidence suggests that GCB-DLBCL and the aggressive ABC/non-GCB subtype of DLBCL use distinct molecular mechanisms to regulate PD-L1 expression, which is preferentially used by the latter to escape recognition and killing by T cells. The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.